CARE vs BPRN

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 03, 2026

CARE

44.6
AI Score
VS
BPRN Wins

BPRN

66.0
AI Score

Investment Advisor Scores

CARE

45score
Recommendation
HOLD

BPRN

66score
Recommendation
STRONG BUY

AI Analyst Insights

Detailed Metrics Comparison

Metric CARE BPRN Winner
Forward P/E 13.6612 11.1982 BPRN
PEG Ratio 0 0 Tie
Revenue Growth 0.1% -33.2% CARE
Earnings Growth 45.8% -84.3% CARE
Tradestie Score 44.6/100 66.0/100 BPRN
Profit Margin 45.7% 25.6% CARE
Beta 1.00 1.00 Tie
AI Recommendation HOLD STRONG BUY BPRN

Relative Price Performance (Last 90 Days)

CARE 1M: -3.2% · 3M: -10.6% BPRN 1M: +2.1% · 3M: +2.0%

Current Technical Phase

CARE

Markdown
Sell / avoid

Price below a falling SMA50 (slope -2.9%), weak momentum, RSI 44

RSI (14): 43.8 · Price: $29.22

BPRN

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (1.5% over 20 days), RSI 53

RSI (14): 53.2 · Price: $44.29

Fundamentals Snapshot

Metric CARE BPRN
Market Cap — —
Forward P/E 11.7 11.3
Trailing P/E 5.0 14.9
Revenue (TTM) — —
Revenue Growth 0.0% -0.3%
Gross Margin 1.0% 1.0%
Operating Margin 0.2% 0.1%
EPS 5.91 2.99
Dividend Yield 0.01% 0.03%

Frequently Asked Questions

Based on our detailed analysis, BPRN is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.